Telehealth and COVID-19 Pandemic: An Overview of the Telehealth Use, Advantages, Challenges, and Opportunities during COVID-19 Pandemic
Open accessThe DOI matches its Crossref record; 78 of the 82 references it cites were found in a registry or an index; 117 of the 187 sources its claims cite were checked for support.
Abstract
The use of telehealth and digital health platforms has increased during the COVID-19 pandemic due to the implementation of physical distancing measures and restrictions. To address the pandemic threat, telehealth was promptly and extensively developed, implemented, and used to maintain continuity of care offered through multi-purpose technology platforms considered as virtual healthcare facilities. The aim of this paper is to define telehealth and discuss some aspects of its utilization, role, and impact, but also opportunities and future implications particularly during the COVID-19 pandemic. In order to support our reflection and consolidate our viewpoints, numerous bibliographical sources and relevant literature were identified through an electronic keyword search of four databases (PubMed, Web of Science, Google Scholar, and ResearchGate). In this paper, we consider that telehealth to be a very interesting approach which can be effective and affordable for health systems aiming to facilitate access to care, maintain quality and safety of care, and engage patients and health professionals and users of health services. However, we also believe that telehealth faces many challenges, such as the issue of lack of human contact in care, confidentiality, and data security, also accessibility and training in the use of platforms for telehealth. Despite the many challenges it faces, we believe telehealth has enormous potential for strengthening and improving healthcare services. In this paper, we also call for and encourage further studies to build a solid and broad understanding of telehealth challenges with its short-term and long-term clinical, organizational, socio-economic, and ethical impacts.
Overview
CoChat Summary
TL;DR
This reflexive overview argues that telehealth expanded massively during COVID-19 and can be effective and affordable for improving access, quality, and patient engagement, but it faces challenges around loss of human contact, confidentiality and data security, accessibility, and training. The authors call for continued investment and further research into telehealth's short- and long-term clinical, organizational, socio-economic, and ethical impacts.
Key findings
- Telehealth use surged during the pandemic: in the US, from 13,000/week to 1.7 million/week post-COVID-19, described as over 13,000% growth in telehealth visits by October 2020; in Ontario, users rose from 1.6% (Q2 2019) to 70.6% (Q2 2020); in British Columbia, teleconsultations with internal medicine physicians rose from 10% to 80.7%; pan-Canadian phone consultations grew from 43.9% to 97.6% and virtual online consultations from 19.3% to 41.2%.
- In a Chinese physician survey, 94.6% used telemedicine during the pandemic, with 34.1% having never used it before; in Miller et al.'s study of 4548 remote physical therapy sessions, 94% of surveyed participants were satisfied and 92% would attend remotely even outside a pandemic.
- Reported benefits include improved chronic-disease self-management, real-time data collection and monitoring, better patient–professional communication and shared decision-making, reduced infection transmission, lower costs and travel time, and improved intrahospital communication and patient safety.
- Reported challenges include loss of human contact and empathy, concerns about clinical safety, confidentiality and data security, inadequate use in rural and lower-income populations, socio-economic disparities in access and digital literacy, and malpractice liability concerns; globally, females used telecare about twice as often as males, with young adults (20–44) the most frequent users.
Methods
Reflexive overview paper (explicitly not a literature review or systematic review), supported by a keyword search of four databases (PubMed, Web of Science, Google Scholar, ResearchGate) using terms such as Telehealth OR telecare OR telemedicine OR e-health OR mobile health apps AND the COVID-19 pandemic. The search was confined to peer-reviewed papers; unpublished papers and grey literature were excluded. No formal screening, extraction, or synthesis procedure is described; findings are presented as the authors' viewpoints supported by cited sources.
Limitations
The paper states that its goal was not a literature review or systematic review, that grey literature and unpublished papers were excluded, and that further studies are needed to build a solid and broad understanding of telehealth's short- and long-term clinical, organizational, socio-economic, and ethical impacts. Evident from the text: no search dates, inclusion/exclusion criteria, screening process, or data-extraction method are reported, and many claims are attributed to single studies or to the authors' own perspective, so the overview is narrative and opinion-based rather than systematically synthesized.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
35 Valid · 4 Not valid · 30 Not checked · 16 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Studies have shown that telehealth offers patients the possibility of collecting and monitoring, in real-time, a set of data specific to their health or their diseases without the physical presence and direct intervention of health professionals [15,16].”
§ Telehealth and COVID-19 Pandemic: An Overview of the Telehealth Use, Advantages, Challenges, and Opportunities during COVID-19 Pandemic > 1. Context > 1.2. Advantages and Benefits
What the sources say
- Partly supportedcites [15] Speyer, 2018, Effects of telehealth by allied health professionals and nurses in rural and remote areas: A systematic review and meta-analysis, J. Rehabil. Med. sourceExperimental — accuracy not yet measured
The Abstract (p. 1) of Speyer et al. defines telehealth as technology-mediated communication between patient and provider, with telephone, video-conference and internet applications allowing consultations, assessments and interventions 'to be provided over a distance' — this supports the distance/no-in-person-presence element of the claim. However, no passage in our copy describes telehealth as enabling patients themselves to collect and monitor health or disease data in real time without the direct intervention of health professionals; searches for 'real-time', 'remote monitoring', 'patient data collection' and the definition section returned only the communication/service-delivery framing and unrelated reference-list entries. The patient-facing real-time self-monitoring component of the attributed claim is therefore not stated in this source. (LLM, conf=0.72)
- Partly supportedcites [16] Vitacca, 2018, How will telemedicine change clinical practice in chronic obstructive pulmonary disease?, Ther. Adv. Respir. Dis. sourceExperimental — accuracy not yet measured
The Introduction (p.1) supports the core of the attribution: telehealth is 'the use of information and communication technologies (ICT) to deliver healthcare services and transmit medical data over long and short distances', telemonitoring is 'the use of ICT to monitor patients at a distance', and the 'Clinical findings' section describes programs designed 'to enhance symptom self monitoring by patients and their caregivers' — i.e. patients collecting their own health data away from the clinic. Two elements of the quoted sentence are not this paper's: the blanket 'in real-time' (the 'Telehealth opportunities' section says first-generation systems transfer measurements asynchronously by store-and-forward and second-generation ones can delay 'if the systems are not active 24 h/day'), and 'without the physical presence and direct intervention of health professionals' — the paper explicitly frames telemonitoring as including 'the follow-up response by a healthcare professional' and states in 'Future directions' that 'Remote monitoring alone is not sufficient for successful disease management.' So the source backs remote patient data collection/monitoring but not the real-time, professional-free characterization. (LLM, conf=0.72)
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Then, when telehealth and COVID-19 remote monitoring platforms were introduced, these areas quickly reported a decline in the mortality rate [20,21].”
§ Telehealth and COVID-19 Pandemic: An Overview of the Telehealth Use, Advantages, Challenges, and Opportunities during COVID-19 Pandemic > 1. Context > 1.2. Advantages and Benefits
What the sources say
- Partly supportedcites [20] Corden, 2020, A targeted response to the COVID-19 pandemic: Analysing effectiveness of remote consultations for triage and management of routine dermatology referrals, Clin. Exp. Dermatol. sourceExperimental — accuracy not yet measured
The Abstract and Report describe telephone and video consultations introduced to manage routine dermatology referrals during the COVID-19 lockdown. They do not describe COVID-19 patient-monitoring platforms or report any decline in mortality; the recorded outcomes concern referral management. No page number is available in our copy. (LLM, conf=0.82)
- Could not verifycites [21] Gebbia, 2020, Patients with cancer and COVID-19: A WhatsApp messenger-based survey of patients’ queries, needs, fears, and actions taken, JCO Glob. Oncol. sourceExperimental — accuracy not yet measured
The Patients and Methods section describes a WhatsApp survey of queries from patients with cancer, not an evaluation of COVID-19 remote-monitoring platforms. The Discussion says the study is a snapshot with no comparison over time. Searches for mortality, telehealth, and remote monitoring found no report of a decline in mortality after their introduction. (LLM, conf=0.76)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Furthermore, in health systems [20], telehealth could improve access to healthcare facilities over distance and outside of working time [19,20,21] and can be an alternative solution to lower hospital admissions for acute conditions [20].”
§ Telehealth and COVID-19 Pandemic: An Overview of the Telehealth Use, Advantages, Challenges, and Opportunities during COVID-19 Pandemic > 1. Context > 1.2. Advantages and Benefits
What the sources say
- Partly supportedcites [20] Corden, 2020, A targeted response to the COVID-19 pandemic: Analysing effectiveness of remote consultations for triage and management of routine dermatology referrals, Clin. Exp. Dermatol. sourceExperimental — accuracy not yet measured
Our copy supports only the general direction: remote (telephone/video) consultations triaged a large volume of ROUTINE, non-urgent dermatology referrals and 'reduce the need for F2F clinic appointments' (Learning points) and discharged over a third of patients 'reducing the need for further outpatient clinic appointment slots' (Report). It nowhere reports hospital admissions as an outcome, and it does not study acute conditions — the cohort is explicitly 816 routinely referred patients whose appointments were suspended, with emergency/on-call referrals described only as a separate pathway (Abstract/Report intro). The paper's own scope claim is hedged: remote consulting 'may be a temporary solution for other COVID-19 impacted dermatology departments' (Abstract), not an alternative solution for lowering acute admissions. Searches for 'hospital admission / inpatient / emergency department / acute presentation' returned no relevant passage, so the 'lower hospital admissions for acute conditions' element attributed to [20] is not in this source. (LLM, conf=0.72)
plainstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Telehealth services might substantially improve patients’ care and treatment, specifically in areas where there are limited resources [20], and structures, or with a dense population where providing adequate care is challenging, and access to healthcare facilities is limited.”
§ Telehealth and COVID-19 Pandemic: An Overview of the Telehealth Use, Advantages, Challenges, and Opportunities during COVID-19 Pandemic > 1. Context > 1.2. Advantages and Benefits
What the sources say
- Partly supportedcites [20] Corden, 2020, A targeted response to the COVID-19 pandemic: Analysing effectiveness of remote consultations for triage and management of routine dermatology referrals, Clin. Exp. Dermatol. sourceExperimental — accuracy not yet measured
Our copy supports the general thrust: the Learning points state that 'Remote consultations are an effective process to manage a large volume of referrals efficiently and reduce the need for F2F clinic appointments', and the Abstract/Report record that over a third of referrals were discharged with advice/treatment initiated remotely, concluding the process 'has been shown to be feasible, and may be a temporary solution for other COVID-19 impacted dermatology departments'. However, the specific qualifier the claim carries — improvement 'in areas where there are limited resources' (and, in the citing sentence, dense populations with limited access to facilities) — is absent: the paper describes a single UK district general dermatology department responding to pandemic-mandated suspension, with a depleted workforce, not resource-poor or geographically underserved settings. It also notes limits relevant to the claim, e.g. patients lacking equipment/capability for imaging or video calls (Report). So the source supports telehealth's effectiveness for care and treatment in this pandemic context but not the resource-limited-area generalization. (LLM, conf=0.75)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“As a demonstration, in China, at the beginning of the pandemic, a higher fatality rate of COVID-19 was shown in those areas with limited resources and access to health compared to the areas with adequate access to healthcare facilities [20,21].”
§ Telehealth and COVID-19 Pandemic: An Overview of the Telehealth Use, Advantages, Challenges, and Opportunities during COVID-19 Pandemic > 1. Context > 1.2. Advantages and Benefits
What the sources say
- Could not verifycites [20] Corden, 2020, A targeted response to the COVID-19 pandemic: Analysing effectiveness of remote consultations for triage and management of routine dermatology referrals, Clin. Exp. Dermatol. sourceExperimental — accuracy not yet measured
Our copy of Corden et al. (2020) is entirely a UK district general dermatology service report: the Abstract (p.1047) and Report sections (pp.1047-1050) describe suspension of routine dermatology work under NHS guidance, remote telephone/video triage of 816 cancelled referrals, and outcomes for 488 patient contacts. No passage addresses China, regional differences in COVID-19 fatality, or resource/healthcare-access disparities; searches for 'China COVID-19 fatality rate limited resources access to healthcare', 'mortality rate higher in areas with inadequate healthcare facilities', and 'Wuhan China deaths case fatality early pandemic' returned only these UK service passages. The absence of the point is not itself a contradiction, so the claim cannot be checked against this source. (LLM, conf=0.70)
- Could not verifycites [21] Gebbia, 2020, Patients with cancer and COVID-19: A WhatsApp messenger-based survey of patients’ queries, needs, fears, and actions taken, JCO Glob. Oncol. sourceExperimental — accuracy not yet measured
Our copy of Gebbia et al. (a WhatsApp-messenger survey of 446 Italian cancer patients) contains no passage about Chinese areas differing in resources or access to healthcare facilities. Its China mortality statements are at patient level only: the INTRODUCTION/CONTEXT says COVID-19–related fatal disease was 'more frequently recorded in older patients with severe comorbidities' (citing Zhou et al., ref 5), and the INTRODUCTION gives a 2%-8% fatality 'depending on population characteristics'; Liang et al. and Wang/Yu et al. are cited for higher death risk in patients with cancer, especially lung cancer. Nothing in the DISCUSSION or References addresses a geographic/resource-access gradient in fatality, so this source cannot support or contradict the claim as printed. (LLM, conf=0.72)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
32 more claims · 23 with their cited sources checked
Create a free account to see all 85 claims and to verify the 70 references still open.
- It may state two separate claims as one. 29
- Probably not a substantial claim. 23
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The pandemic has therefore forced health care providers to adapt quickly to the new reality of delivering care remotely, leading to a significant increase in the adoption and use of telemedicine globally [3,20].”
From Public and Research Interest in Telemedicine From 2017 to 2022: Infodemiology Study of Google Trends Data and Bibliometric Analysis of Scientific Literature (2024) · cites this paper as [20]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Telehealth and COVID-19 Pandemic: An Overview of the Telehealth Use, Advantages, Challenges, and Opportunities during COVID-19 Pandemic > 1. Context > 1.4. COVID-19 Impacts on Telehealth
“Koonin et al. described an over 13,000% growth in telehealth visits in practically all sectors and specialties in October 2020 [48,49,50].”
§ Telehealth and COVID-19 Pandemic: An Overview of the Telehealth Use, Advantages, Challenges, and Opportunities during COVID-19 Pandemic > References
“48. Dawes M. Beerman S. Gelfer M. Hobson B. Khan N. Kuyper L. Mangat B. Tran K. Wilson M.G. Kaczorowski J. The challenges of measuring blood pressure during COVID-19: How to integrate and support home blood pressure measurements”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Telehealth and COVID-19 Pandemic: An Overview of the Telehealth Use, Advantages, Challenges, and Opportunities during COVID-19 Pandemic > 1. Context > 1.2. Advantages and Benefits
“Miller et al. [30] corroborated these benefits in their study on the adoption of telemedicine physical therapy services in the context of the COVID-19 pandemic.”
§ Telehealth and COVID-19 Pandemic: An Overview of the Telehealth Use, Advantages, Challenges, and Opportunities during COVID-19 Pandemic > References
“30. Mubaraki A.A. Alrabie A.D. Sibyani A.K. Aljuaid R.S. Bajaber A.S. Mubaraki M.A. Advantages and disadvantages of telemedicine during the COVID-19 pandemic era among physicians in Taif, Saudi Arabia”
Citations
Cites
Virtually perfect? Telemedicine for COVID-19
Hollander, J. E., & Carr, B. G. (2020) · New England Journal of Medicine · doi:10.1056/nejmp2003539 · Cited by 2,970 · cited 2×
“Others are worried about the practical and clinical safety, quality, confidentiality, and data security [37–39].”
BackgroundThe role of telehealth during COVID-19 outbreak: a systematic review based on current evidence
Monaghesh, E., & Hajizadeh, A. (2020) · BMC Public Health · doi:10.1186/s12889-020-09301-4 · Cited by 1,941 · cited 1×
“In Australia, a national study suggests that the COVID-19 pandemic considerably encouraged and promoted the use of telehealth and thanks to this window of opportunity, a lot of progress was made in the domain that, without that progress, telehealth use would have remained infrequent [50–58].”
BackgroundTelehealth transformation: COVID-19 and the rise of virtual care
Wosik, J., Fudim, M., Cameron, B., Gellad, Z. F., Cho, A., Phinney, D., Curtis, S., Roman, M., Poon, E. G., Ferranti, J., et al. (2020) · Journal of the American Medical Informatics Association · doi:10.1093/jamia/ocaa067 · Cited by 1,581 · cited 2×
“Now, even with the decline in COVID-19, several countries are still investing more and more in the development and promotion of telehealth to prevent the chaos we saw in the early beginning of the pandemic in 2020 and to better manage any further global health crises [71–73].”
BackgroundCOVID-19: towards controlling of a pandemic
Bedford, J., Enria, D., Giesecke, J., Heymann, D. L., Ihekweazu, C., Kobinger, G., Lane, H. C., Memish, Z., Oh, M.-D., Sall, A. A., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30673-5 · Cited by 1,545 · cited 1×
“Due to the absence of proper vaccines and treatments in the early stages of the pandemic, approaches such as lockdown, quarantine, and physical distancing were implemented to slow down the spread and reduce the impact of the disease [1,2].”
BackgroundCOVID-19 transforms health care through telemedicine: Evidence from the field
Mann, D. M., Chen, J., Chunara, R., Testa, P. A., & Nov, O. (2020) · Journal of the American Medical Informatics Association · doi:10.1093/jamia/ocaa072 · Cited by 1,361
COVID-19: Protecting health-care workers
Lancet, T. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30644-9 · Cited by 1,247 · cited 2×
“…to estimate the number of patients spared from contamination cases thanks to the use of telehealth and remote monitoring platforms; however, studies in the United States, Switzerland, and Germany suggest that telehealth has tremendously helped reduce and slow down the spread of coronavirus [62–66].”
BackgroundDorsey, E. R., & Topol, E. J. (2016) · New England Journal of Medicine · doi:10.1056/nejmra1601705 · Cited by 1,211 · cited 1×
“), to improve their state of health and their quality of life, reduce their symptoms, and strengthen their self-management skills [13,14].”
BackgroundThe Role of Telehealth in Reducing the Mental Health Burden from COVID-19
Zhou, X., Snoswell, C. L., Harding, L. E., Bambling, M., Edirippulige, S., Bai, X., & Smith, A. C. (2020) · Telemedicine and e-Health · doi:10.1089/tmj.2020.0068 · Cited by 1,159
Telehealth Benefits and Barriers
Gajarawala, S. N., & Pelkowski, J. N. (2021) · The Journal for Nurse Practitioners · doi:10.1016/j.nurpra.2020.09.013 · Cited by 987 · cited 1×
“As telehealth usage develops, so will the risk of fraud and misuse, necessitating rigorous legislation to keep the operations legitimate and correct [44,45].”
BackgroundTuckson, R. V., Edmunds, M., & Hodgkins, M. L. (2017) · New England Journal of Medicine · doi:10.1056/nejmsr1503323 · Cited by 907
Research works printed but not linked: 1
- Onwuegbuzie, A.J., and Frels, R. (2016). Seven Steps to a Comprehensive Literature Review: A Multimodal and Cultural Approach, SAGE Publishing.
Cited by
Mumtaz, H., Riaz, M. H., Wajid, H., Saqib, M., Zeeshan, M. H., Khan, S. E., Chauhan, Y. R., Sohail, H., & Vohra, L. I. (2023) · Frontiers in Digital Health · doi:10.3389/fdgth.2023.1203945 · Cited by 301
Machine Learning for Healthcare-IoT Security: A Review and Risk Mitigation
Khatun, M. A., Memon, S. F., Eising, C., & Dhirani, L. L. (2023) · IEEE Access · doi:10.1109/access.2023.3346320 · Cited by 179
Survey of Transfer Learning Approaches in the Machine Learning of Digital Health Sensing Data
Chato, L., & Regentova, E. E. (2023) · Journal of Personalized Medicine · doi:10.3390/jpm13121703 · Cited by 79
COVID-19 and Tuberculosis: Unveiling the Dual Threat and Shared Solutions Perspective
Cioboată, R., Biciuşcă, V., Olteanu, M., & Vasile, C. M. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12144784 · Cited by 71
Canfell, O. J., Woods, L. S., Meshkat, Y., Krivit, J., Gunashanhar, B., Slade, C., Burton‐Jones, A., & Sullivan, C. M. (2024) · Journal of Medical Internet Research · doi:10.2196/47715 · Cited by 90
“COVID-19 initiated the rapid adoption of virtual health care [115], and clinical applications of AI are rapidly emerging as the future primary disruptors of health care [116].”
Metadata
- Authors
- Bouabida, K., Lebouché, B., & Pomey, M.-P.
- Affiliations
- Centre Hospitalier de l’Université de Montréal (CA)
- McGill University Health Centre (CA)
- Corresponding author
- Pomey, Marie-Pascale
- Venue
- Healthcare
- Publisher
- MDPI AG
- Published
- 2022-11-16
- Volume
- 10
- Issue
- 11
- Pages
- 2293
- ISSN
- 2227-9032 (ISSN-L)
- PMC
- PMC9690761
- OpenAlex
- W4309312736
- Cited by
- 179
- References
- 82
- Citations by year
- 2026: 22 · 2025: 60 · 2024: 69 · 2023: 28
- FWCI
- 34.61
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Healthcare (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Canadian Institutes of Health Research (VR4−172769, 311200, LE 250)
- Quebec Health Research Fund (FRQS) (VR4−172769, 311200, LE 250)
- Centre de recherche du Centre hospitalier de l’Université de Montréal and the Ministère de la Santé et des Services sociaux du Québec (VR4−172769, 311200, LE 250)
- Fonds de recherche du Québec–Santé (FRQS) (VR4−172769, 311200, LE 250)
- Quebec’s Ministry of Health (VR4−172769, 311200, LE 250)
- CareSimple Health Group (VR4−172769, 311200, LE 250)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Telemedicine and Telehealth Implementation
- Health Sciences › Dentistry › General Dentistry › Dental Research and COVID-19
- Physical Sciences › Computer Science › Information Systems › Healthcare during COVID-19 Pandemic
- Keywords
- telemedicine, COVID-19 pandemic, digital health platforms, continuity of care, health care access, social distancing, confidentiality, data security, patient engagement, health professions education
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-07, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-07 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (qwen3.8-omni-flash and gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Telehealth and COVID-19 Pandemic: An Overview of the Telehealth Use, Advantages, Challenges, and Opportunities during COVID-19 Pandemic. https://app.cochat.ai/papers/10.3390/healthcare10112293
- The paper
- Bouabida, K., Lebouché, B., & Pomey, M.-P. (2022). Telehealth and COVID-19 Pandemic: An Overview of the Telehealth Use, Advantages, Challenges, and Opportunities during COVID-19 Pandemic. Healthcare. https://doi.org/10.3390/healthcare10112293
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.